Vitravki and Xospata- Cutting-Edge Cancer Drugs Now Approved by FDA
Two new cutting-edge cancer treatments, Vitravki and Xospata, have now been approved for use by the U.S. Food and Drug Administration (FDA). Both drugs were given Priority Review status, which means the FDA reviewed them in six months instead of ten. This status allows the FDA to quickly approve drugs that promise to make significant […]
Continue readingCould Nano Drugs Be a New Alternative Cancer Treatment?
Treatments against cancerous tumors have always been a dangerous and complicated process. These cancer cells can grow and spread rapidly. In addition, the current available treatments are determined by whether or not the patient can endure the treatment process, and also the location of the tumor. Scientists are now exploring Nano drugs. With the options […]
Continue readingSteep Rise in Prices of Older Cancer Drugs
The study included oral and intravenous chemotherapy cancer drugs covered by Medicare Part B. Medicare is the federal health insurance plan for people 65 or older. “Higher costs lead to higher copays,” said study co-author Dr. Sham Mailankody. He’s a medical oncologist at Memorial Sloan Kettering Cancer Center in New York City. “And empiric research […]
Continue reading